- Home
- AMRN vs RLTY Comparison
AMRN vs RLTY Comparison
Compare AMRN & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- RLTY
- Stock Information
- Founded
- AMRN 1989
- RLTY 2022
- Country
- AMRN Ireland
- RLTY United States
- Employees
- AMRN N/A
- RLTY N/A
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- RLTY Investment Managers
- Sector
- AMRN Health Care
- RLTY Finance
- Exchange
- AMRN Nasdaq
- RLTY Nasdaq
- Market Cap
- AMRN 216.0M
- RLTY 255.0M
- IPO Year
- AMRN 1993
- RLTY N/A
- Fundamental
- Price
- AMRN $15.98
- RLTY $15.61
- Analyst Decision
- AMRN Strong Sell
- RLTY
- Analyst Count
- AMRN 1
- RLTY 0
- Target Price
- AMRN $12.00
- RLTY N/A
- AVG Volume (30 Days)
- AMRN 69.5K
- RLTY 86.7K
- Earning Date
- AMRN 07-30-2025
- RLTY 01-01-0001
- Dividend Yield
- AMRN N/A
- RLTY 9.35%
- EPS Growth
- AMRN N/A
- RLTY N/A
- EPS
- AMRN N/A
- RLTY N/A
- Revenue
- AMRN $219,361,000.00
- RLTY N/A
- Revenue This Year
- AMRN N/A
- RLTY N/A
- Revenue Next Year
- AMRN N/A
- RLTY N/A
- P/E Ratio
- AMRN N/A
- RLTY N/A
- Revenue Growth
- AMRN N/A
- RLTY N/A
- 52 Week Low
- AMRN $7.08
- RLTY $11.38
- 52 Week High
- AMRN $17.49
- RLTY $14.60
- Technical
- Relative Strength Index (RSI)
- AMRN 59.78
- RLTY 60.17
- Support Level
- AMRN $15.54
- RLTY $15.26
- Resistance Level
- AMRN $16.50
- RLTY $15.40
- Average True Range (ATR)
- AMRN 0.48
- RLTY 0.16
- MACD
- AMRN 0.08
- RLTY 0.01
- Stochastic Oscillator
- AMRN 73.06
- RLTY 100.00
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest
Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.